Skip to main navigation Skip to search Skip to main content

Bcl2L13 is a ceramide synthase inhibitor in glioblastoma

  • Samuel A. Jensen
  • , Andrea E. Calvert
  • , Giora Volpert
  • , Fotini M. Kouri
  • , Lisa A. Hurley
  • , Janina P. Luciano
  • , Yongfei Wu
  • , Alexandra Chalastanis
  • , Anthony H. Futerman
  • , Alexander H. Stegh

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bcl2L13 is a ceramide synthase inhibitor in glioblastoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology